Kembali ke Daftar Obat
Panduan penyiapan dan pemberian terapi medikasi
Panduan penyiapan dan pemberian terapi medikasi
Ganciclovir Sodium
Penyiapan
Sediaan
- 500 mg/vial
Rekomendasi Pengenceran (Konsentrasi)
100-250 mL
Pelarut
- D5%
- NaCl 0.9%
- RL
Pemberian
Rekomendasi Akses
IV
Rekomendasi Durasi Pemberian
1 jam (IV Drip)
Stabilitas Obat Setelah Rekonstruksi
1 jam
Keamanan
pH
11
pH risiko tinggi (<4 / >9)
Osmolaritas Sebelum Pengenceran
290-310
Osmolaritas rendah (<600)
Phlebitis
Tidak
Inkompatibilitas
-
Aldesleukin
-
Amifostine
-
Amsacrine
-
Aztreonam
-
Cisatracurium Besylate
-
Fludarabine Phosphate
-
Foscarnet Sodium
-
Gemcitabine HCl
-
Ondansetron HCl
-
Piperacillin Sodium
-
Sargramostim
-
Tacrolimus
- Corticosteroids
Klasifikasi GHS
Health Hazard
Manifestasi GHS
H350 (100%): May cause cancer [Danger Carcinogenicity]
H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]
H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]
Sumber
- National center for biotechnology information. Pubchem database. https://www.mims.com/indonesia/drug/info/ganciclovir?mtype=generic
- Manrique-Rodríguez, S., Heras-Hidalgo, I., Pernia-López, M.S. et al. Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety. Drugs R D 21, 39–64 (2021). https://doi.org/10.1007/s40268-020-00329-w. https://pubchem.ncbi.nlm.nih.gov/compound/Ganciclovir-sodium